East African Lawmakers Push Regional Control of Vaccines

KIGALI, RWANDA — Legislators from the East African Legislative Assembly (EALA) are calling for stronger local oversight over medical procurement. Following a parliamentary mission to Kigali, legislators outlined how local oversight of east african medical supplies can secure pharmaceutical supply chains after identifying a potential $94 million joint procurement pipeline for member states.
According to KT Press, EALA’s Committee on General Purpose visited the Regional Centre of Excellence for Vaccines, Immunization and Health Supply Chain Management. Centre Director John Patrick Mwesigye noted that COVID-19 exposed severe vulnerabilities in globalized distribution networks. Committee Chair David Ole Sankok led the delegation, which included Fidelis Mironko, Permanent Secretary at Rwanda’s Ministry of Foreign Affairs, and EALA member Ilham Ali Gasser.
Regional Health Supply Chain Capacity & Framework
Strategic developments supporting East Africa’s health sovereignty initiative include:
| Capacity / Strategy Pillar | Programmatic Achievement & Scope |
| Specialist Training Workforce | Nearly 500 Master’s graduates and 3,000+ short-course trainees |
| Joint Procurement Target | $94 million in medical commodities identified for pooled buying |
| Strategic Pillars | Specialized training, unified purchasing, and domestic financing |
| Host Institution | Regional Centre of Excellence (University of Rwanda, Kigali) |
Procurement Strategy for East African Medical Supplies
Securing a stable supply of east african medical supplies aims to reduce reliance on external aid donors and fluctuating international supply lines. Pooled procurement allows smaller East African Community (EAC) member states to negotiate bulk purchases collectively, driving down unit costs while improving supplier reliability.
However, operational success depends heavily on harmonizing regulatory standards across member nations. Similar regional procurement models often encounter delays when national drug regulators insist on separate product registrations, payment settlements stall, or domestic manufacturing lobbies oppose unified standards. Securing direct financial commitments from EAC partner states remains vital to creating a self-sustaining medical supply network.
Why It Matters: Pooled buying can significantly cut drug prices for smaller East African countries, provided member states maintain domestic funding and align regulatory approvals.
Source: KT Press, September 2026



